336 related articles for article (PubMed ID: 25511212)
1. Cyclin D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium.
Shevra CR; Ghosh A; Kumar M
J Postgrad Med; 2015; 61(1):15-20. PubMed ID: 25511212
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN
Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573
[TBL] [Abstract][Full Text] [Related]
6. Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas.
Cao QJ; Einstein MH; Anderson PS; Runowicz CD; Balan R; Jones JG
Int J Gynecol Pathol; 2002 Apr; 21(2):147-54. PubMed ID: 11917224
[TBL] [Abstract][Full Text] [Related]
7. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
[TBL] [Abstract][Full Text] [Related]
8. Significance of hormone receptor status and tumor vessels in normal, hyperplastic and neoplastic endometrium.
Nunobiki O; Taniguchi E; Ishii A; Tang W; Utsunomiya H; Nakamura Y; Mori I; Kakudo K
Pathol Int; 2003 Dec; 53(12):846-52. PubMed ID: 14629750
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.
Shawana S; Kehar SI; Masood S; Aamir I
J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
11. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis of endometrial hyperplasia and carcinoma by computerized image cytometry of cell proliferation, apoptosis and Bcl-2 expression.
Mora LB; Diaz JI; Cantor AB; Nicosia SV
Ann Clin Lab Sci; 1999; 29(4):308-15. PubMed ID: 10528831
[TBL] [Abstract][Full Text] [Related]
13. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP
J Clin Pathol; 2008 Jan; 61(1):36-42. PubMed ID: 17483252
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical pattern of protein P21, cyclin D1 and cyclin E in endometrial hyperplasia.
Brucka A; Bartczak P; Ratyńska M; Sporny S
Pol J Pathol; 2009; 60(1):19-25. PubMed ID: 19670700
[TBL] [Abstract][Full Text] [Related]
15. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Study of Ki-67 in Hyperplastic and Endometrium Carcinoma: A Comparative Study.
Ghalib Farhood R; Abd Ali Al-Humairi I
Arch Razi Inst; 2022 Feb; 77(1):229-234. PubMed ID: 35891746
[TBL] [Abstract][Full Text] [Related]
17. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
18. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues.
Brustmann H; Naudé S
Pathol Res Pract; 1999; 195(12):829-34. PubMed ID: 10631718
[TBL] [Abstract][Full Text] [Related]
19. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
